{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T12:19:25Z","timestamp":1789215565166,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03769-7","type":"journal-article","created":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T23:03:31Z","timestamp":1728601411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of aldosterone in various target organ damage in patients with hypertensive emergency: a cross-sectional study"],"prefix":"10.1186","volume":"25","author":[{"given":"Akihiro","family":"Miyake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Horikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaede","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiko","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeki","family":"Fujitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,10]]},"reference":[{"key":"3769_CR1","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1056\/NEJMcp1901117","volume":"381","author":"AJ Peixoto","year":"2019","unstructured":"Peixoto AJ. Acute severe hypertension. N Engl J Med. 2019;381:1843\u201352. https:\/\/doi.org\/10.1056\/NEJMcp1901117.","journal-title":"N Engl J Med"},{"key":"3769_CR2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/ajh\/hpx008","volume":"30","author":"A Shantsila","year":"2017","unstructured":"Shantsila A, Lip GYH. Malignant hypertenson revisited-does this still exist? Am J Hypertens. 2017;30:543\u20139.","journal-title":"Am J Hypertens"},{"key":"3769_CR3","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.amjhyper.2007.02.018","volume":"20","author":"BJ van den Born","year":"2007","unstructured":"van den Born BJ, Koopmans RP, van Montfrans GA. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. Am J Hypertens. 2007;20:900\u20136.","journal-title":"Am J Hypertens"},{"key":"3769_CR4","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1097\/HJH.0000000000002547","volume":"38","author":"P Gosse","year":"2020","unstructured":"Gosse P, Boulestreau R, Brockers C, Puel C, Rubin S, Cremer A. The pharmacological management of malignant hypertension. J Hypertens. 2020;38:2325\u201330.","journal-title":"J Hypertens"},{"key":"3769_CR5","doi-asserted-by":"publisher","first-page":"107788","DOI":"10.1016\/j.exer.2019.107788","volume":"188","author":"MJ Allingham","year":"2019","unstructured":"Allingham MJ, Mettu PS, Cousins SW. Aldosterone as a mediator of severity in retinal vascular disease: evidence and potential mechanisms. Exp Eye Res. 2019;188:107788. https:\/\/doi.org\/10.1016\/j.exer.2019.107788.","journal-title":"Exp Eye Res"},{"key":"3769_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/eurheartj\/ehr292","volume":"33","author":"F Edelmann","year":"2012","unstructured":"Edelmann F, Tomaschitz A, Wachter R, Gelbrich G, Knoke M, D\u00fcngen HD, et al. Serum aldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction. Eur Heart J. 2012;33:203\u201312.","journal-title":"Eur Heart J"},{"key":"3769_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/10641963.2010.503303","volume":"33","author":"T Akimoto","year":"2011","unstructured":"Akimoto T, Muto S, Ito C, Takahashi H, Takeda S, Ando Y, Kusano E. Clinical features of malignant hypertension with thrombotic microangiopathy. Clin Exp Hypertens. 2011;33:77\u201383.","journal-title":"Clin Exp Hypertens"},{"key":"3769_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/jhh.2015.112","volume":"30","author":"A Cremer","year":"2016","unstructured":"Cremer A, Amraoui F, Lip GYH, Morales E, Rubin S, Segura J, et al. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. J Hum Hypertens. 2016;30:463\u20136.","journal-title":"J Hum Hypertens"},{"key":"3769_CR9","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1093\/ndt\/gfq143","volume":"25","author":"R Gonzalez","year":"2010","unstructured":"Gonzalez R, Morales E, Segura J, Ruilope LM, Praga M. Long-term renal survival in malignant hypertension. Nephrol Dial Transpl. 2010;25:3266\u201372.","journal-title":"Nephrol Dial Transpl"},{"key":"3769_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1161\/01.HYP.0000151620.17905.ee","volume":"45","author":"BJH van den Born","year":"2005","unstructured":"van den Born BJH, Honnebier UPK, Koopmans RP, van Montfrans GA. Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension. 2005;45:246\u201351.","journal-title":"Hypertension"},{"issue":"1","key":"3769_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12882-023-03117-1","volume":"24","author":"K Endo","year":"2023","unstructured":"Endo K, Hayashi K, Hara Y, Miyake A, Takano K, Horikawa T, et al. Impact of early initiation of renin-angiotensin blockade on renal function and clinical outcomes in patients with hypertensive emergency: a retrospective cohort study. BMC Nephrol. 2023;24(1):68. https:\/\/doi.org\/10.1186\/s12882-023-03117-1.","journal-title":"BMC Nephrol"},{"key":"3769_CR12","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Asociation of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440\u201363.","journal-title":"J Am Soc Echocardiogr"},{"key":"3769_CR13","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"3769_CR14","doi-asserted-by":"publisher","first-page":"e935135","DOI":"10.12659\/MSM.935135","volume":"28","author":"J Dziedziak","year":"2022","unstructured":"Dziedziak J, Zaleska-Zmijewska A, Szaflik JP, Cudnoch-Jedrzejewska A. Impact of arterial hypertension on the eye: a review of the pathogenesis, diagnostic methods, and treatment of hypertensive retinopathy. Med Sci Monit. 2022;28:e935135.","journal-title":"Med Sci Monit"},{"key":"3769_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mce.2009.02.005","volume":"308","author":"C Grossmann","year":"2009","unstructured":"Grossmann C, Gekle M. New aspects of rapid aldosterone signaling. Mol Cell Endocrinol. 2009;308:53\u201362.","journal-title":"Mol Cell Endocrinol"},{"issue":"12 Pt B","key":"3769_CR16","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1016\/j.bbadis.2014.05.036","volume":"1842","author":"B Schmitz","year":"2014","unstructured":"Schmitz B, Brand SM, Brand E. Aldosterone signaling and soluble adenylyl cyclase-a nexus for the kidney and vascular endothelium. Biochim Biophys Acta. 2014;1842(12 Pt B):2601\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"3769_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/01.fjc.0000211738.63207.c3","volume":"47","author":"Y Hashikabe","year":"2006","unstructured":"Hashikabe Y, Suzuki K, Jojima T, Uchida K, Hattori Y. Aldosterone impairs vascular endothelial cell function. J Cardiovasc Pharmacol. 2006;47:609\u201313.","journal-title":"J Cardiovasc Pharmacol"},{"key":"3769_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1042\/cs1030425","volume":"103","author":"CAJ Farquharson","year":"2002","unstructured":"Farquharson CAJ, Struthers AD. Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin Sci. 2002;103:425\u201331.","journal-title":"Clin Sci"},{"key":"3769_CR19","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41440-020-0521-2","volume":"44","author":"E Mishima","year":"2021","unstructured":"Mishima E, Funayama Y, Suzuki T, Mishima F, Nitta F, Toyohara T, Kikuchi K, Kunikata H, Hashimoto J, Miyazaki M, Harigae H, Nakazawa T, Ito S, Abe T. Concurrent analogous organ damage in the brain, eyes, and kidneys in malignant hypertension: reversible encephalopathy, serous retinal detachment, and proteinuria. Hypertens Res. 2021;44:88\u201397. https:\/\/doi.org\/10.1038\/s41440-020-0521-2.","journal-title":"Hypertens Res"},{"key":"3769_CR20","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1097\/01.ASN.0000078960.15147.05","volume":"14","author":"PN Chander","year":"2003","unstructured":"Chander PN, Roha R, Ranaudo J, Singh G, Zuckerman A, Stier CT Jr. Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP. J Am Soc Nephrol. 2003;14:1990\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"3769_CR21","first-page":"893","volume":"120","author":"CG Brilla","year":"1992","unstructured":"Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med. 1992;120:893\u2013901.","journal-title":"J Lab Clin Med"},{"key":"3769_CR22","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12872-022-02837-w","volume":"22","author":"A Kolkenbeck-Rush","year":"2022","unstructured":"Kolkenbeck-Rush A, Soepnel LM, Criuch SH, Naidoo S, Smith W, Norris SA, Davies J, et al. Obesity, hypertension, and tobacco use associated with left ventricular remodeling and hypertrophy in South Africa women: birth to Twenty Plus Cohort. BMC Cardiovasc Disord. 2022;22:403. https:\/\/doi.org\/10.1186\/s12872-022-02837-w.","journal-title":"BMC Cardiovasc Disord"},{"key":"3769_CR23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/bmj.1.6163.579","volume":"1","author":"C Isles","year":"1979","unstructured":"Isles C, Brown JJ, Cumming AM, Lever AF, McAreavey D, Robertson JI, et al. Excess smoking in malignant-phase hypertension. Br Med J. 1979;1:579\u201381.","journal-title":"Br Med J"},{"key":"3769_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/ATVBAHA.113.300156","volume":"34","author":"B Messner","year":"2014","unstructured":"Messner B, Bernhard D. Smoking and cardiovascular disease -mechanisms of endothelial dysfunction and early atherogenesis. Arteriolscler Thromb Vasc Biol. 2014;34:509\u201315.","journal-title":"Arteriolscler Thromb Vasc Biol"},{"key":"3769_CR25","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/bmj.1.6163.581","volume":"1","author":"CA Bloxham","year":"1979","unstructured":"Bloxham CA, Beever DG, Walker JM. Malignant hypertension and cigarette smoking. Br Med J. 1979;1:581\u20133.","journal-title":"Br Med J"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03769-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03769-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03769-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T15:04:17Z","timestamp":1728659057000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03769-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,10]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3769"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03769-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,10]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board and Ethics Committee of Tokyo Bay Urayasu-Ichikawa Medical Center with waiver of the requirement for obtaining informed consent (approval No. 726) and was conducted in accordance with the Declaration of Helsinki. Information from medical records was anonymized prior to final analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"342"}}